Conference on 'Brain damage risk and neuroprotectants for preterm newborns', Hamburg, Germany
8 October 2009 - 8 October 2009
Germany
A conference on 'Brain damage risk and neuroprotectants for preterm newborns' will be held in Hamburg, Germany, on 8 October 2009.
Organised by the EU-funded NEOBRAIN ('Neonatal estimation of brain damage risk and identification of neuroprotectants') project, the event will present state-of-the-art results from the project and related areas of research.
The brain is particularly vulnerable in preterm infants. Damage during this time of brain development can subsequently lead to motor deficits, cognitive limitations, attention deficits, learning difficulties and even severe disabilities. Within the NEOBRAIN project, researchers, clinicians and companies from across Europe collaborate in order to identify strategies to diagnose and to protect the newborn brain against such injury.
All interested participants are welcome to attend the conference, especially those involved in the diagnosis, healthcare management and neuroprotection of newborns with perinatal brain damage.For further information, please visit:
http://www.i-med.ac.at/neobrain/news/(opens in new window)
Organised by the EU-funded NEOBRAIN ('Neonatal estimation of brain damage risk and identification of neuroprotectants') project, the event will present state-of-the-art results from the project and related areas of research.
The brain is particularly vulnerable in preterm infants. Damage during this time of brain development can subsequently lead to motor deficits, cognitive limitations, attention deficits, learning difficulties and even severe disabilities. Within the NEOBRAIN project, researchers, clinicians and companies from across Europe collaborate in order to identify strategies to diagnose and to protect the newborn brain against such injury.
All interested participants are welcome to attend the conference, especially those involved in the diagnosis, healthcare management and neuroprotection of newborns with perinatal brain damage.For further information, please visit:
http://www.i-med.ac.at/neobrain/news/(opens in new window)